Abstract

BackgroundMicroRNAs (miRs) control gene expression and the development of the immune system and antiviral responses. MiR-155 is an evolutionarily-conserved molecule consistently induced during viral infections in different cell systems. Notably, there is still an unresolved paradox for the role of miR-155 during viral respiratory infections. Despite being essential for host antiviral TH1 immunity, miR-155 may also contribute to respiratory disease by enhancing allergic TH2 responses and NFkB-mediated inflammation. The central goal of this study was to define how airway miR-155 production is related to TH1, TH2, and pro-inflammatory cytokine responses during naturally occurring viral respiratory infections in young children.MethodsNormalized nasal airway levels of miR-155 and nasal protein levels of IFN-γ, TNF-α, IL-1β, IL-13, IL-4 were quantified in young children (≤2 years) hospitalized with viral respiratory infections and uninfected controls. These data were linked to individual characteristics and respiratory disease parameters.ResultsA total of 151 subjects were included. Increased miR-155 levels were observed in nasal samples from patients with rhinovirus, RSV and all respiratory viruses analyzed. High miR-155 levels were strongly associated with high IFN-γ production, increased airway TH1 cytokine polarization (IFN-γ/IL-4 ratios) and increased pro-inflammatory responses. High airway miR-155 levels were linked to decreased respiratory disease severity in individuals with high airway TH1 antiviral responses.ConclusionsThe airway secretion of miR-155 during viral respiratory infections in young children is associated with enhanced antiviral immunity (TH1 polarization). Further studies are needed to define additional physiological roles of miR-155 in the respiratory tract of human infants and young children during health and disease.

Highlights

  • MicroRNAs are small non-coding RNA molecules that control gene expression and critically regulate the development of the immune system and antiviral responses [1,2]

  • Increased miR-155 levels were observed in nasal samples from patients with rhinovirus, respiratory syncytial virus (RSV) and all respiratory viruses analyzed

  • The airway secretion of miR-155 during viral respiratory infections in young children is associated with enhanced antiviral immunity (TH1 polarization)

Read more

Summary

Introduction

MicroRNAs (miRNAs) are small non-coding RNA molecules that control gene expression and critically regulate the development of the immune system and antiviral responses [1,2]. One of the most investigated miRNAs in immunology and virology is miR-155 [3,4,5,6] The interest in this molecule was initially motivated by the discovery that miR-155 is the only miRNA substantially induced by the synthetic viral intermediate poly(I:C) or the host antiviral interferon (IFN) response in macrophages [7]. Over the past decade many studies in humans and animal models have confirmed that miR-155 is an evolutionarily-conserved molecule consistently induced during viral infections in different cell systems [7,8,9,10,11,12]. MicroRNAs (miRs) control gene expression and the development of the immune system and antiviral responses. The central goal of this study was to define how airway miR-155 production is related to TH1, TH2, and proinflammatory cytokine responses during naturally occurring viral respiratory infections in young children

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call